Acasti Pharma Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
25 Sep 23 | BuyUS$1,249,934 | Vimal Kavuru | Individual | 676,371 | US$1.85 | |
25 Sep 23 | BuyUS$1,250,001 | Vimal Kavuru | Individual | 676,371 | US$1.85 | |
31 Aug 23 | BuyUS$781 | Donald Olds | Individual | 381 | US$2.05 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 124,344 | 1.32% |
VC/PE Firms | 567,812 | 6.04% |
Institutions | 574,326 | 6.11% |
Individual Insiders | 2,412,362 | 25.7% |
General Public | 5,720,560 | 60.9% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 26.4%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
1,188,076 | US$3.3m | 0% | no data | |||
781,592 | US$2.2m | 0% | no data | |||
567,812 | US$1.6m | 0% | 0.67% | |||
494,698 | US$1.4m | 0% | no data | |||
370,354 | US$1.0m | -25.1% | no data | |||
124,344 | US$345.7k | 0% | no data | |||
37,895 | US$105.3k | 0% | no data | |||
34,532 | US$96.0k | 0% | 0.04% | |||
31,000 | US$86.2k | 0% | no data | |||
21,357 | US$59.4k | 0% | no data | |||
11,119 | US$30.9k | 0% | no data | |||
5,602 | US$15.6k | 18.9% | no data | |||
3,062 | US$8.5k | 0.13% | no data | |||
2,901 | US$8.1k | 0% | no data | |||
1,882 | US$5.2k | 0% | no data | |||
1,094 | US$3.0k | 0% | no data | |||
875 | US$2.4k | 0% | no data | |||
584 | US$1.6k | 0% | no data | |||
41 | US$115.0 | 0% | no data | |||
13 | US$36.6 | 8.33% | no data | |||
9 | US$26.1 | 0% | no data | |||
2 | US$5.2 | 0% | no data |